Follow
CAR-T Cell therapy Lymphoma
Chimeric antigen receptor T (CAR-T) cells are immune cells that have been genetically engineered in a laboratory to display an artificial T cell receptor enabling them to target a specified protein more effectively. CAR-T cell therapy can be used to treat lymphoma by engineering cells attracted to the antigens, specific molecules expressed on lymphoma cells.
-
APR 06, 2017Videos
While research and testing for new cancer drugs is vital, it also takes time. A new treatment that has shown promise in ...Written By: Brenda Kelley KimFEB 18, 2016Health & Medicine
Dramatic remissions have been seen in a cancer immunotherapy trial for patients with blood cancers. Specifically, ...Written By: Julianne ChiaetNOV 02, 2015Immunology
B-cell leukemia occurs in 80-85 percent of children with acute lymphoblastic leukemia (ALL), a fast-growing cancer that ...Written By: Kara MarkerSEP 13, 2015Cancer
A team at the University of Pennsylvania reported that a multiple myeloma patient whose cancer had stopped respondi ...Written By: Ilene Schneider
APR 06, 2017
Videos
While research and testing for new cancer drugs is vital, it also takes time. A new treatment that has shown promise in
...
Written By:
Brenda Kelley Kim
FEB 18, 2016
Health & Medicine
Dramatic remissions have been seen in a cancer immunotherapy trial for patients with blood cancers. Specifically,
...
Written By:
Julianne Chiaet
NOV 02, 2015
Immunology
B-cell leukemia occurs in 80-85 percent of children with acute lymphoblastic leukemia (ALL), a fast-growing cancer that
...
Written By:
Kara Marker
SEP 13, 2015
Cancer
A team at the University of Pennsylvania reported that a multiple myeloma patient whose cancer had stopped respondi
...
Written By:
Ilene Schneider